Matthieu Egloff

Dr. Matthieu Egloff

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
MTMathieu Thabault
Mathieu Thabault
VTValentine Turpin
Valentine Turpin
AMAlexandre Maisterrena
Alexandre Maisterrena
Mohamed JABERMohamed JABER
Mohamed JABER
MEMatthieu Egloff
Matthieu Egloff
LAURIE GALVANLAURIE GALVAN
LAURIE GALVAN
Autism spectrum disorders (ASD) are complex conditions that stem from a combination of genetic, epigenetic and environmental influences during early pre- and postnatal childhood. The review focuses on the cerebellum and the striatum, two structures involved in motor, sensory, cognitive and social functions altered in ASD. We summarize clinical and fundamental studies highlighting the importance of these two structures in ASD. We further discuss the relation between cellular and molecular alterations with the observed behavior at the social, cognitive, motor and gait levels. Functional correlates regarding neuronal activity are also detailed wherever possible, and sexual dimorphism is explored pointing to the need to apprehend ASD in both sexes, as findings can be dramatically different at both quantitative and qualitative levels. The review focuses also on a set of three recent papers from our laboratory where we explored motor and gait function in various genetic and environmental ASD animal models. We report that motor and gait behaviors can constitute an early and quantitative window to the disease, as they often correlate with the severity of social impairments and loss of cerebellar Purkinje cells. The review ends with suggestions as to the main obstacles that need to be surpassed before an appropriate management of the disease can be proposed.

1 October 2017 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
ARAlexandre Rouen
Alexandre Rouen
LCLéa Carlier
Léa Carlier
SHSolveig Heide
Solveig Heide
MEMatthieu Egloff
Matthieu Egloff
PMPauline Marzin
Pauline Marzin
JSJean-Pierre Siffroi
Jean-Pierre Siffroi

1 January 2015 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
PDF file
VMValérie Malan
Valérie Malan
JLJean-Michel Lapierre
Jean-Michel Lapierre
MEMatthieu Egloff
Matthieu Egloff
DGDidier Goidin
Didier Goidin
MBMarie-Paule Beaujard
Marie-Paule Beaujard
CTCatherine Turleau
Catherine Turleau
Cytogenetic microarray analysis is now the first-tier genetic test used in a postnatal clinical setting to explore genomic imbalances in individuals with developmental disability and/or birth defects. However, in a prenatal setting, this technique is not widely implemented, largely because the clinical impact of some copy number variants (CNVs) remains difficult to assess. This limitation is especially true in France where termination of pregnancy for medical reasons may be performed at any stage of gestation. During a period of 15 months, we investigated 382 fetuses presenting with ultrasound anomalies, using a customized microarray designed to avoid the detection of CNVs raising challenges for genetic counseling. After excluding common aneuploidies, 20/374 (5.3%) fetuses had a pathogenic CNV, among which 12/374 (3.2%) could have been detected by karyotyping, whereas 8/374 (2.1%) were cryptic. Within these 374 cases, 300 were ongoing pregnancies at the time of array comparative genomic hybridization (aCGH) testing. For these pregnancies, we detected 18/300 (6%) pathogenic CNVs, among which 6/300 (2%) were cryptic. Using this approach, only 2/300 (0.6%) of the detected CNVs raised difficulties for genetic counseling. This study confirms the added value of this strategy in a prenatal clinical setting to minimize ethical issues for genetic counseling while enhancing the detection of genomic imbalances.

5 October 2022 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
GJGuillaume Jouret
Guillaume Jouret
MEMatthieu Egloff
Matthieu Egloff
ELEmilie Landais
Emilie Landais
OTOlivier Tassy
Olivier Tassy
FGFabienne Giuliano
Fabienne Giuliano
CPCéline Poirsier
Céline Poirsier

15 November 2014 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
PDF file
MEMatthieu Egloff
Matthieu Egloff
FEFerechte Encha-Razavi
Ferechte Encha-Razavi
CGCatherine Garel
Catherine Garel
MBMaryse Bonnière-Darcy
Maryse Bonnière-Darcy
AMAnne-Elodie Millischer
Anne-Elodie Millischer
VMValérie Malan
Valérie Malan
Ultrasound examination performed on a 36-year-old woman at 33 weeks of gestation showed the presence of isolated and bilateral ventriculomegaly in the fetus. Array-based comparative genomic hybridization (array-CGH) performed on uncultured amniocytes at 35 weeks of gestation revealed a 17q21.31 microdeletion. After genetic counseling, the pregnancy was terminated at 37 weeks of gestation. At autopsy, the fetus displayed facial dysmorphic features and triventricular ventriculomegaly. To our knowledge, this is the first case of a 17q21.31 microdeletion detected prenatally. Our report suggests that array-CGH should be performed when severe ventriculomegaly is observed in prenatal ultrasound examination.

6 July 2020 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
TNTanguy Niclass
Tanguy Niclass
GGGwenael Le Guyader
Gwenael Le Guyader
CBClaire Beneteau
Claire Beneteau
MJMadeleine Joubert
Madeleine Joubert
APAntonio Pizzuti
Antonio Pizzuti
MEMatthieu Egloff
Matthieu Egloff